Login
$CNTX
$0.18 +$0.01 (5.61%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Martin Lehr Also a director
Director, President and Chief Executive Officer
42 Not stated Not stated $1,465,430
Jennifer Minai-Azary
Chief Financial Officer and Treasurer
48 Since 2021
5 years
2021 $866,139
Karen Chagin
Chief Medical Officer
49 Since 2025
1 year
2025 Not reported
Alex Levit
Chief Legal Officer and Corporate Secretary
47 Not stated 2021 $816,671

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
1 of 2
stated in the proxy; 5 not stated
Average tenure
4.9 years
from year joined
CEO also chairs the board
No
Andy Pasternak
Director Age On board Independent Committees Other public boards 2025 pay Source
Andy Pasternak
55 2025
1 year
Independent
Audit
None stated $159,027
Martin Lehr
42 2015
11 years
Not independent None stated None stated Paid as CEO
Philip Kantoff, MD
71 2018
8 years
Not stated None stated None stated $111,135
Karen Smith, MD, PhD, MBA, LLM
58 2024
2 years
Not stated None stated Sangamo Therapeutics, Inc., Skye Bioscience, Inc. Not stated
Jennifer Evans Stacey, Esq.
61 2021
5 years
Not stated None stated None stated $122,635
Luke Walker, MD
54 2024
2 years
Not stated None stated Zentalis Pharmaceuticals $111,135
Linda West
67 2021
5 years
Not stated None stated None stated $127,359

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support